DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance

Wolfgang Gruber(University of Salzburg), Fritz Aberger(University of Salzburg)
Oncotarget
January 13, 2016
Cited by 65


Related Papers